| Annual Financials | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | TTM |
Revenue  | 11 | 17 | 27 | 25 | 30 | 33 | 33 | 19 |
| Expenses | 11 | 17 | 26 | 22 | 29 | 30 | 28 | 18 |
| EBITDA | 0 | 0 | 1 | 3 | 1 | 3 | 5 | 1 |
| Operating Profit % | 1 % | 2 % | 4 % | 12 % | 3 % | 9 % | 14 % | 6 % |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 |
| Profit Before Tax | 0 | 0 | 1 | 3 | 1 | 3 | 4 | 1 |
| Tax | 0 | 0 | 0 | 1 | 0 | 1 | 1 | -0 |
| Net Profit | 0 | 0 | 1 | 2 | 0 | 2 | 3 | 2 |
| EPS in ₹ | 0.37 | 1.66 | 2.59 | 6.81 | 0.68 | 4.66 | 7.20 | 6.60 |
Sunrest Lifescience
Sunrest Lifescience
34.00
-1.00
(-2.86%)
Market Cap
29.18 Cr
PE Ratio
3.76
Volume
4,800.00
Day High - Low
34.00 - 34.00
52W High-Low
61.00 - 29.55
Key Fundamentals
Market Cap
29.18 Cr
EPS
7.20
PE Ratio
3.76
PB Ratio
1.22
Book Value
28.81
EBITDA
4.82
Dividend Yield
0.00 %
Industry
Healthcare Sector
Pharmaceuticals Return on Equity
12.36
Debt to Equity
0.41
Actual
Company News
View All News
Sunrest Lifescience reported a consolidated net profit of ₹411.63 lakh for FY26, up from ₹200.56 lakh in the previous year. Revenue from operations increased to ₹7083.29 lakh.
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
1,788.50 | #1 4,29,121.06 | 37.31 | #1 58,220.10 | 6.38 | #1 11,565 | 25.80 | 44.37 | |
6,576.50 | 1,74,585.41 | 67.49 | 10,560.00 | 8.73 | 2,520 | 13.44 | 46.75 | |
4,368.50 | 1,47,849.89 | 68.30 | 13,753.00 | 19.18 | 2,028 | -26.91 | 50.11 | |
1,375.20 | 1,11,086.00 | 28.84 | 27,711.70 | -2.46 | 3,783 | -55.32 | 52.65 | |
1,076.60 | 1,08,331.15 | 21.16 | 26,719.70 | 13.65 | 5,242 | 7.82 | 68.91 | |
1,263.30 | 1,05,440.45 | 25.59 | 33,593.30 | -0.44 | 3,998 | -86.05 | 41.47 | |
2,261.20 | 1,03,346.61 | #1 19.21 | 27,487.50 | 19.98 | 5,345 | #1 87.72 | 45.17 | |
2,369.50 | 97,814.16 | 48.97 | 14,277.60 | 12.03 | 1,750 | 31.75 | 50.42 | |
1,440.40 | 83,658.67 | 23.70 | 33,384.70 | 3.21 | 3,376 | 1.99 | 48.90 | |
1,394.30 | 75,272.20 | 83.88 | 6,812.90 | #1 21.03 | 884 | 21.18 | 76.00 |
Automatic Screeners on ScanX
Growth Rate
Revenue Growth
0.48 %
Net Income Growth
54.50 %
Cash Flow Change
109.66 %
ROE
677.36 %
ROCE
206.96 %
EBITDA Margin (Avg.)
59.93 %
Yearly Financial Results
Balance Sheet
| Balance Sheet | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
| Total Assets | 6 | 10 | 13 | 17 | 25 | 35 | 41 |
| Fixed Assets | 0 | 0 | 1 | 0 | 0 | 1 | 3 |
| Current Assets | 6 | 9 | 13 | 16 | 25 | 28 | 33 |
| Capital Work in Progress | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 11 |
| Other Assets | 6 | 9 | 13 | 16 | 25 | 34 | 0 |
| Total Equity & Liabilities | 6 | 10 | 13 | 17 | 25 | 35 | 41 |
| Current Liabilities | 4 | 7 | 9 | 12 | 8 | 15 | 14 |
| Non Current Liabilities | 2 | 2 | 3 | 2 | 4 | 4 | 8 |
| Total Equity | 0 | 0 | 1 | 3 | 14 | 16 | 19 |
| Reserve & Surplus | 0 | 0 | 1 | 0 | 10 | 12 | 15 |
| Share Capital | 0 | 0 | 0 | 3 | 4 | 4 | 4 |
Cash Flow
| Cash Flow | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Net Cash Flow | 0 | 0 | 0 | 0 | -0 | 0 |
| Investing Activities | 0 | -0 | -0 | 0 | 0 | -1 |
| Operating Activities | -1 | 0 | -0 | 1 | -15 | 1 |
| Financing Activities | 1 | 0 | 1 | -1 | 15 | -0 |
Share Holding
| % Holding | Nov 2023 | Mar 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 |
| Promoter | 69.91 % | 69.91 % | 69.91 % | 69.91 % | 69.91 % | 69.91 % | 53.50 % | 53.50 % | 53.50 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| DIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 25.24 % | 24.46 % | 24.87 % | 24.83 % | 24.94 % | 24.27 % | 36.02 % | 34.90 % | 36.35 % |
| Others | 4.85 % | 5.63 % | 5.22 % | 5.26 % | 5.15 % | 5.82 % | 10.48 % | 11.60 % | 10.14 % |
| No of Share Holders | 742 | 580 | 505 | 487 | 459 | 455 | 498 | 491 | 492 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 28 Sept 2024 |  Annual General Meeting | NA | 28 Sept 2024 | 61.40 | 60.45 |
| 14 Nov 2024 |  Quarterly Result Announcement | NA | 14 Nov 2024 | 56.15 | 57.00 |
| 30 May 2025 | Quarterly Result Announcement | NA | 30 May 2025 | 56.50 | 52.05 |
| 13 Nov 2025 | Quarterly Result Announcement | NA | 13 Nov 2025 | 46.50 | 47.20 |
| 23 Mar 2026 |  Rights | 1:1 | 23 Mar 2026 | 46.00 | 44.60 |
| 29 May 2026 | Quarterly Result Announcement | NA | 29 May 2026 | 36.00 | 35.00 |
Technical Indicators
RSI(14)
Neutral 44.87
ATR(14)
Less Volatile 1.73
STOCH(9,6)
Oversold 13.33
STOCH RSI(14)
Oversold 18.13
MACD(12,26)
Bearish -0.10
ADX(14)
Weak Trend 9.83
UO(9)
Bearish 33.60
ROC(12)
Downtrend And Accelerating -3.05
WillR(14)
Oversold -100.00
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
